Jean Lozach

Jean Lozach

Jean joined OnRamp Bio after more than 25 years experience in Genomics, Bioinformatics and Information Technology at Illumina and UCSD. As Associate Director of Enterprise Informatics over the last 5 years, Jean was instrumental to the setup and customer success for Illumina's BaseSpace solution for bioinformatics. He uniquely brings deep experience and knowledge of biology, wet lab operations, microarrays, and next generation sequencing together with advanced bioinformatics, software development and enterprise IT infrastructure. Jean is recognized as an industry expert in genomics and bioinformatics, and has led tens of successful customer deployments of next generation sequencing and informatics systems. At Illumina, he also provided leadership and support for all Enterprise Informatics applications, including BaseSpace Sequence Hub, NextBio tools, Genome Studio, Variant Studio and Variant Interpreter. Jean holds a Masters in Computer Science from Institut national des Sciences appliquées de Toulouse / INSA Toulouse, and a B.S. Computer Science from IUT de Clermont-Ferrand - Université d'Auvergne.

Recent posts by Jean Lozach

3 min read

Multi-Omics for Every Scientist

By Jean Lozach on Jun 2, 2020 7:29:21 AM

I’m convinced, and I know most of you are too, that we will not get to a complete understanding of diseases and biology in general without looking behind a multi-omics lens. While NGS radically democratized access to genomics information with RNA-seq, for example, the complexity of other assays like ChIP-seq and the ensuing challenges in combining different types of data analyses have limited the wide scale adoption of multi-omics approaches.

Topics: BioInformatics GenomeWeb Epigenetics Meta-Analysis Collaboration
2 min read

Poster: Genomic Modalities to Drug Development for S. Mansoni

By Jean Lozach on Jul 16, 2019 8:05:48 PM


Schistosoma mansoni causes schistosomiasis, a disease of poverty that infects approximately 200 million people worldwide. Treatment of the disease relies on praziquantel (PZQ). With the expanding use of the drug, there is a fear over the development of resistance. It is, therefore, important to discover new drugs and drug targets.

I'm really happy to announce  another poster and research project utilizing ROSALIND, our analysis and collaboration platform for genomics.

Topics: BioInformatics Rosalind RNAseq Collaboration UCSD
2 min read

ROSALIND WINS BEST OF SHOW AT BIO-IT WORLD 2018

By Jean Lozach on Jun 8, 2018 9:43:00 AM

OnRamp takes home the "People's Choice - Best of Show" award at BioIT-World 2018 in Boston.
Click here to try ROSALIND for free
Topics: Personalized Medicine Transcriptome BioInformatics Rosalind Epigenetics
4 min read

Come See ROSALIND at Bio-IT World 2018

By Jean Lozach on May 11, 2018 1:52:23 PM

As proud contender for Bio-IT World's "People's Choice - Best in Show", ROSALIND will have latest features presented throughout the event

Event: Bio-IT World

Dates: 5/15/18 - 5/17/18

Location: Seaport World Trade Center, Boston MA

Event URL: www.bio-itworld.com/

Topics: Personalized Medicine Transcriptome BioInformatics Rosalind Epigenetics
1 min read

ROSALIND Featured at #TRICON 2018!

By Jean Lozach on Feb 6, 2018 1:29:39 PM

OnRamp's CEO, Tim Wesselman, features ROSALIND™ during Plenary Keynote Panel on Emerging Technologies and Industry Perspectives

Event: Molecular Medicine Tri-Conference

Date/Time: February 14th @ 8:45a PT

Location: San Francisco Moscone Convertion Hall

Event URL: http://www.triconference.com/

Topics: Personalized Medicine Transcriptome BioInformatics Rosalind Epigenetics
1 min read

OnRamp’s Rosalind™ overcomes limitations found in existing data analysis tools

By Jean Lozach on Oct 11, 2017 3:19:41 PM

Our mission is to transform how cancer researchers and biologists analyze their data (at SCALE)!

Advanced bioinformaticians deserve all of the credit for building state-of-the-art applications to analyze genomic, proteomic, and microarray data.  While these tools remain the lifeline of genomic analysis, more simplified user experiences are now required to empower today’s cancer biologists to focus on their research application, not which software application to use. 

Topics: Big Data Cancer Pipelines BioInformatics Biology Rosalind